Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

NCT05411107 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Agent is not available

Conditions

Bronchial Epithelial Dysplasia
Chronic Obstructive Pulmonary Disease
Lung Carcinoma
Stage I Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Tobacco-Related Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bronchial Brush Biopsy
PROCEDURE: Bronchoscopy
DRUG: Iloprost
DRUG: Placebo Administration
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)